Drug
PXS-4728A clinical trials
Also written BI 1467335.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2016
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
10 studies that test it; most in 2017 (5)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Studies
Open first, then newest update. How each study uses PXS-4728A is read from its arms, and is right about nine times in ten.
Testing it · 10
- This Study in Healthy Men Tests How the Body Takes up BI 1467335CompletedPhase 1Boehringer IngelheimNCT03483506Written as BI 1467335
- A Study in Healthy Men to Test the Effects of Different Doses of BI 1467335 on MAO-B Activity in the Brain.CompletedPhase 1Boehringer IngelheimNCT03927209Written as BI 1467335
- This Study Tests BI 1467335 in Healthy Male Volunteers. The Study Tests How Different Doses of BI 1467335 Are Taken up and Handled by the BodyCompletedPhase 1Boehringer IngelheimNCT03382509Written as [14C]BI 1467335
- To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1467335 Following Multiple Dose Administration Over 28 DaysCompletedPhase 1Boehringer IngelheimNCT02733627Written as BI 1467335
- Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male SubjectsCompletedPhase 1Boehringer IngelheimNCT02999191Written as BI 1467335 (Treatment A)
- A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 1467335 is Processed in the BodyCompletedPhase 1Boehringer IngelheimNCT03302091Written as BI 1467335
- A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.CompletedPhase 2Boehringer IngelheimNCT03238963Written as BI 1467335
- This Study Tests BI 1467335 in Healthy Japanese and Caucasian Men. The Study Tests How Different Doses of BI 1467335 Are Taken up in the Body and How Well They Are ToleratedCompletedPhase 1Boehringer IngelheimNCT03159455Written as BI 1467335
- A Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood PressureTerminatedPhase 1Boehringer IngelheimNCT03979820Written as BI 1467335
- Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASHCompletedPhase 2Boehringer IngelheimNCT03166735Written as BI 1467335
Codes
What other systems call PXS-4728A · ClinicalTrials.gg INT015334
- Wikidata Q27265609pxs-4728aOne source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27265609 | pxs-4728a | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.